
Evidence that plaque can shrink: CENIT, PRECISE-IVUS, ZEUS, EVAPORATE and GLAGOV
Post by group member Daniel Chong summarising trials showing plaque change: supervised HIIT in CENIT, ezetimibe in PRECISE-IVUS, ezetimibe added to statin in ZEUS, icosapent ethyl in EVAPORATE and evolocumab in GLAGOV. It notes some research suggests a 1% reduction in plaque volume may equate to a 20% reduction in event risk.

































